Age and Sex Differences in Efficacy of Treatments for Type 2 Diabetes: A Network Meta-Analysis.
Hanlon P. et al, (2025), JAMA
The legacy effect of hyperglycaemia in type 2 diabetes - Authors' reply.
Adler AI. et al, (2025), Lancet, 405
An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
De Giorgi R. et al, (2025), Nature Mental Health
Cardiovascular Risk Prediction Scores in Type 1 Diabetes: A Systematic Review and Meta-Analysis
Erqou S. et al, (2025), JACC: Advances, 4
The Diabetes Technology Society Error Grid and Trend Accuracy Matrix for Glucose Monitors.
Klonoff DC. et al, (2024), J Diabetes Sci Technol
Going beyond randomised controlled trials to assess treatment effect heterogeneity across target populations.
Lugo-Palacios DG. et al, (2024), Health Econ
Evaluation of hydroxychloroquine or chloroquine for the prevention of COVID-19 (COPCOV): A double-blind, randomised, placebo-controlled trial.
Schilling WHK. et al, (2024), PLoS Med, 21
Examining the impact of structural uncertainty across ten type 2 diabetes models: Results from the 2022 Mount Hood Challenge.
Altunkaya J. et al, (2024), Value Health
Overcoming challenges in the economic evaluation of interventions to optimise antibiotic use
ROOPE L. et al, (2024), Communications Medicine
ASCEND-Eye: Effects of Omega-3 Fatty Acids on Diabetic Retinopathy.
Sammons EL. et al, (2024), Ophthalmology, 131, 526 - 533
12-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort study
De Giorgi R. et al, (2024), eClinicalMedicine
Diabetes mellitus in Kabuki syndrome 1 on a background of post-transplant diabetes mellitus.
Chew Sue Mei S. et al, (2024), Endocrinology, diabetes & metabolism case reports, 2024, 23 - 133
Healthcare-Associated Respiratory Syncytial Virus in Children's Hospitals.
Saiman L. et al, (2023), J Pediatric Infect Dis Soc, 12, 265 - 272